Showing 13,341 - 13,360 results of 22,665 for search '(( 2 step decrease ) OR ( 100 ((teer decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 0.95s Refine Results
  1. 13341

    TUNEL staining and cell proliferation in the OB by Haydn M Prosser (40070)

    Published 2011
    “…Note, the difference in size of the OB at 5 × magnification. Scale bars: 100 µm (A and B); 20 µm (C); 500 µm (E and F).…”
  2. 13342

    Table 1_Trends in the burden of urolithiasis in China: an analysis from the global burden of disease study 2021.xlsx by Yangyang Lin (3797422)

    Published 2025
    “…</p>Result<p>The age-standardised prevalence rate of urolithiasis in China has decreased from 96.23 per 100,000 in 1992 to 50.78 per 100,000 in 2021 for males and from 34.44 per 100,000 in 1992 to 22.04 per 100,000 in 2021 for females. …”
  3. 13343

    Effect of irradiated nonionic surfactant on drug-protein binding by E. Paul Raj (18494331)

    Published 2024
    “…The drug solutions in methanol-aqueous media were combined with BSA in the initial step. In the next two succeeding steps, drug–BSA interaction in the presence of unirradiated and irradiated surfactants were carried out. …”
  4. 13344

    Datasheet1_Improvement of the gait pattern after selective dorsal rhizotomy derives from changes of kinematic parameters in the sagittal plane.docx by Wenbin Jiang (5663266)

    Published 2022
    “…</p>Results<p>In total, 32 cases were included in this study, with a mean age of 5.9 ± 2.1 years old. Noticeable decrease was found in the median value of the pre-operational MAS score after SDR at last follow-up in both sides of adductors, gastrocnemius, soleus, and left hamstrings. …”
  5. 13345

    Baseline progression risk for the model in the top part of <b>Table 4</b>, for a non-black participant in the San Francisco Veterans Affairs Medical Center liver studies cohort [17... by Peter Bacchetti (75155)

    Published 2013
    “…For the transition from stage 2 to 3, the estimated hazard of progression is 0.55 for the first step and 0 at all later times; this is not shown to avoid compression of the vertical scale for the other transitions. …”
  6. 13346

    Inhibition of DC Expansion following TMEV Infection via Apoptosis and Growth Arrest by Wanqiu Hou (78785)

    Published 2007
    “…<div><p>(A) BMCs were cultured with GM-CSF for 3 d and then mock-infected or infected with TMEV. …”
  7. 13347

    Loss of <i>Lmx1b</i> alters the size of the FP, the mDA progenitor domain, and ventral midbrain patterning. by Angela Anderegg (496917)

    Published 2013
    “…(N–T) In 13.5 dpc <i>En1::Cre;Lmx1bcKO</i> embryos we found a nearly complete loss of Islet+ oculomotor neurons (n = 3; control mean = 223.11±16.42, mutant mean = 0.33±0.33; p-value = .0002), a 39% decrease in Brn3a+ red nucleus neurons (n = 3; control mean = 752.22±82.42, mutant mean = 455.78±10.56; p-value = .02), and a 68% decrease in Lmx1a+ mDA lineage cells (n = 3; control mean = 951.33±10.63, mutant mean = 308.89±18.99; p-value = 7.84E = 06). …”
  8. 13348

    Exploiting Temporal Network Structures of Human Interaction to Effectively Immunize Populations by Sungmin Lee (166210)

    Published 2012
    “…<div><p>Decreasing the number of people who must be vaccinated to immunize a community against an infectious disease could both save resources and decrease outbreak sizes. …”
  9. 13349

    Table 1_Potential shared gene signatures and molecular mechanisms between recurrent pregnancy loss and ovarian cancer.docx by Yan Wang (15435)

    Published 2024
    “…</p>Methods<p>The 71 differentially expressed genes associated with RPL and 1427 genes associated with OV survival were analyzed, among which 7 common genes were both important in the pathogenesis of RPL and OV. Then stepAIC analysis was performed to simplify the model and decrease the number of genes, which yielded a final set of 5 prognostic genes with coefficients to construct a prognostic risk scoring system. …”
  10. 13350

    Table_3_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.DOC by Lorenzo Di Cesare Mannelli (600627)

    Published 2018
    “…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
  11. 13351

    Propagation of GABA-induced hyperpolarization at the axon regulates AP generation. by Yang Xia (104600)

    Published 2014
    “…Right, group data showing a decrease in the mean frequency of APs after GABA iontophoresis at the axon trunk. **, P<0.01, paired t-test. …”
  12. 13352

    The effect of (+)-pentazocine and H<sub>2</sub>O<sub>2</sub> on ONHAs viability. by Jing Zhao (21160)

    Published 2017
    “…At the highest concentration of PTZ (50μM), there was a trend toward decrease in viability that was not significant. …”
  13. 13353

    Table_2_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.doc by Lorenzo Di Cesare Mannelli (600627)

    Published 2018
    “…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
  14. 13354

    Table_1_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.doc by Lorenzo Di Cesare Mannelli (600627)

    Published 2018
    “…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
  15. 13355

    Image_1_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.TIF by Lorenzo Di Cesare Mannelli (600627)

    Published 2018
    “…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
  16. 13356

    Image_1_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.TIF by Lorenzo Di Cesare Mannelli (600627)

    Published 2018
    “…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
  17. 13357

    Table_2_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.doc by Lorenzo Di Cesare Mannelli (600627)

    Published 2018
    “…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
  18. 13358

    Table_1_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.doc by Lorenzo Di Cesare Mannelli (600627)

    Published 2018
    “…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
  19. 13359

    Table_3_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.DOC by Lorenzo Di Cesare Mannelli (600627)

    Published 2018
    “…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
  20. 13360

    Image_2_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.TIF by Lorenzo Di Cesare Mannelli (600627)

    Published 2018
    “…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”